Company Overview of Genomics USA, Inc.
Genomics USA, Inc. develops and fabricates micro array technologies to bypass DNA purification and quantitation by allowing human leukocyte antigen (HLA) typing directly from raw blood (rehydrated) dried blood spots on Guthrie cards and from raw buccalswabs. It offers HLA Chip technology based on HLA typing for tissue transplantation and stem cell therapeutics, as well as based on HLA analysis for vaccine development, personalized vaccine delivery, personalized treatment for autoimmune diseases, and personalized treatment of microbial infection. Genomics USA was incorporated in 2004 and is based in Inverness, Illinois.
1622 West Colonial Parkway
Inverness, IL 60067
Founded in 2004
Key Executives for Genomics USA, Inc.
Genomics USA, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Genomics USA, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.